Hello from Dianne Miller
Thanks for that intro, Doug. I’m very pleased to be the BC Cancer Foundation’s guest blogger for the month of July and to share with …
General
Pediatric Cancer Research and Metastatic Diseases
Pediatric cancer research is gaining recognition as an area of excellence at the BC Cancer Agency. I touched on some of the reasons …
Dr. Poul Sorensen: My Background
I’m originally from Denmark, but have lived in Canada since I was about nine years old. My family first moved to Victoria, then to …
The Jambor-McCarthy legacy: A $21.4 million Gift Twenty Years in the Making
…just a brief interruption of Dr. Shah’s posts, to share some exciting breaking news: This morning, we announced the largest charitable bequest to a single …
A closer look at acute myeloid leukemia (AML)
Eventually, I wanted to enhance the bridging of my clinical and research work, and the BC Cancer Agency was—and continues to be—a …
About me—From Queen’s to Vancouver
Hello, my name is Aly Karsan and I am the head of the Centre for Clinical Diagnostic Genomics and the Medical Director of the …
Cancer Speak: November 4, 2011
I’m really excited about what’s to come with Dr. Aly Karsan’s posts, but I had to take this chance to talk about some timely …
Introducing Dr. Aly Karsan
Around the office at the BC Cancer Foundation we are still thrilled with the success of last week’s Inspiration Gala event. To those …
Phase I Clinical Trials and Drug Development
Dr. Gelmon continues her blog for the BC Cancer Foundation, talking about Phase I Clinical Trials and Drug Development.
Understanding Tumours
When I began treating breast cancer, we treated patients according to whether they were pre-menopausal or not, and whether there was any sign of …